Driehaus Capital Management LLC Madrigal Pharmaceuticals, Inc. Transaction History
Driehaus Capital Management LLC
- $11.8 Billion
- Q3 2025
A detailed history of Driehaus Capital Management LLC transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Driehaus Capital Management LLC holds 115,974 shares of MDGL stock, worth $59.7 Million. This represents 0.45% of its overall portfolio holdings.
Number of Shares
115,974Holding current value
$59.7 Million% of portfolio
0.45%Shares
2 transactions
Others Institutions Holding MDGL
# of Institutions
391Shares Held
23.2MCall Options Held
654KPut Options Held
490K-
Baker Bros. Advisors LP New York, NY2.14MShares$1.1 Billion8.0% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.09MShares$1.08 Billion32.86% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$1.03 Billion12.22% of portfolio
-
Janus Henderson Group PLC London, X01.84MShares$949 Million0.41% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.83MShares$944 Million11.49% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $8.81B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...